Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / People / Maher Masoud
Person

Maher Masoud

Tracked across 1 events · 6 articles · First seen Jul 21, 2026 · Last active Jul 22, 2026

Sentiment
40
Attention
2
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
2 40
Business
MaxCyte-Genentech cell therapy license
Impact: Maher Masoud, as President and CEO of MaxCyte, announced the partnership and is credited with securing the deal, which reflects positively on his leadership.
Jul 21, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Maher Masoud live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.